Bloomberg Law
July 19, 2016, 9:43 PM

Cancer ‘Moonshot’ Changes to Benefit All Disease Research

The White House’s cancer “moonshot” initiative will benefit research across disease groups as changes implemented address systemic issues that hamper research progress, a White House aide said July 19.

“Cancer is a great place to start with the culture change because we’ll be able to see the benefit much more quickly than we can in other diseases where we know far less,” Greg Simon, executive director of the White House Cancer Moonshot Task Force, said during a webinar. “But you don’t want to wait until those diseases are as mature as cancer in our knowledge and then change ...